orthofix
-
Spine
Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years
Additionally, analysis of two-year physiological range of motion data from multiple artificial cervical disc IDE studies to be presented showing…
Read More » -
Regulatory
FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions
May 4, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Biologics
Orthofix and MTF Biologics Expand Partnership Agreement
May 3, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Spine
Orthofix Announces New Business Unit President
Kimberley Elting, Chief Legal and Development Officer for Orthofix, Appointed to Lead Global Orthopedics Business April 8, 2022 LEWISVILLE, Texas–(BUSINESS…
Read More » -
Regulatory
Orthofix Announces FDA Clearance and First Patient Cases With the TrueLok EVO Ring Fixation System
Designed for complex limb reconstruction and deformity correction procedures, the system features radiolucent rings and struts for clearer visualization under…
Read More » -
Financial
Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results
Fourth quarter net sales of $125.1 million, an increase of 6% over the prior year2021 annual net sales of $464.5…
Read More » -
Biologics
Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures
February 22, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Financial
Orthofix Announces Investment and Partnership with nView medical, Developer of Novel Imaging and Guidance Systems
January 19, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Extremities
Orthofix Announces Appointment of Thomas A. West to Board of Directors
December 14, 2021 Thomas A. West LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine…
Read More » -
Financial
Orthofix Announces Appointment of Wayne Burris to Board of Directors
September 23, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Biologics
Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures
September 21, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Extremities
Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System
September 1, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Financial
Orthofix Reports Second Quarter 2021 Results
Net sales of $121 million, up 66% compared to prior year and 5% compared to the second quarter of 2019U.S.…
Read More » -
Regulatory
Orthofix Announces First Patient Implant in the M6-C Artificial Cervical Disc Two-Level IDE Study
August 2, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Spine
Orthofix Announces US Launch and First Patient Implants with New fiberFUSE Strip – An Advanced Fiber Bone-Graft Solution Containing Cancellous Bone
July 28, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More »